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Abstract
Background: The results from the published studies on the association between angiotensin-converting enzyme (ACE)
insertion/deletion (I/D) gene polymorphism and the treatment response to steroid in Asian children with idiopathic
nephrotic syndrome (INS) is still conflicting. This meta-analysis was performed to evaluate the relation between ACE I/D
gene polymorphism and treatment response to steroid in Asian children and to explore whether ACE D allele or DD
genotype could become a predictive marker for steroid responsiveness.
Methodology/Principal Findings: Association studies were identified from the databases of PubMed, Embase, Cochrane
Library and CBM-disc (China Biological Medicine Database) as of September 1, 2010, and eligible investigations were
synthesized using meta-analysis method. Five investigations were identified for the analysis of association between ACE I/D
gene polymorphism and steroid-resistant nephrotic syndrome (SRNS) risk in Asian children and seven studies were included
to explore the relationship between ACE I/D gene polymorphism and steroid-sensitive nephrotic syndrome (SSNS)
susceptibility. Five investigations were recruited to explore the difference of ACE I/D gene distribution between SRNS and
SSNS. There was no a markedly association between D allele or DD genotype and SRNS susceptibility or SSNS risk, and the
gene distribution differences of ACE between SRNS and SSNS were not statistically significant. II genotype might play a
positive role against SRNS onset but not for SSNS (OR=0.51, P=0.02; OR=0.95, P=0.85; respectively), however, the result
for the association of II genotype with SRNS risk was not stable.
Conclusions/Significance: Our results indicate that D allele or DD homozygous can’t become a significant genetic
molecular marker to predict the treatment response to steroid in Asian children with INS.
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Introduction
Idiopathic nephrotic syndrome (INS) is the most common
glomerular disease in childhood [1], and uniformly present as
proteinuria, hypoalbuminemia, hyperlipidemia and gravity-de-
pendent edema, with other features like hematuria, hypertension,
and decreased glomerular filtration rate [2]. With a benign
prognosis, most of INS have a satisfactory response to steroid
therapy [3]. According to the clinical response to steroids, INS are
divided into steroid-sensitive nephrotic syndrome (SSNS) and non-
steroid-sensitive nephrotic syndrome (non-SSNS), and non-SSNS
is further divided into steroid-dependent nephrotic syndrome
(SDNS) and steroid-resistant nephrotic syndrome (SRNS) [4]. Age
of initial presentation has an important impact on the disease
distribution and the response to steroid [5]. Most of children with
INS respond to corticosteroid treatment (SSNS), and about 10%
of children with INS are mainly steroid-resistant (SRNS) [6].
SRNS is at risk of developing end stage renal disease [7]. In
clinical practice, the best prognostic indicator for INS is whether
or not the disease responds to steroid treatment [8]. Patients with
SSNS or SRNS have a similar clinical manifestation, and there is
no specific laboratory indicator to distinguish these two clinical
entities [1]. Pathological evaluation of renal cortical tissue, by
means of a renal biopsy, has traditionally been used to detect a
distinction between SSNS and SRNS [1]. The pathological
correlations to SSNS and SRNS are minimal change disease
and focal segmental glomerulosclerosis, respectively. However,
these histological diagnoses aren’t always parallel to patients’
clinical response to treatment. Identification of noninvasive
biomarkers that accurately distinguish SSNS from SRNS would
be most beneficial to the patients with SRNS, preventing their
exposure to high-dose, yet ineffective steroid courses [1]. In the
past years, some investigations suggested that there might be an
association between angiotensin-converting enzyme (ACE) inser-
tion/deletion (I/D) gene polymorphism and treatment response to
steroid in children with INS and DD genotype or D allele might
become a candidate indicator for predicting the response to
corticosteroid treatment.
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renin-angiotensin system (RAS) is involved in the pathogenesis of
renal disorders [9,10,11,12]. ACE, a key zinc metallopeptidase,
catalyses the conversion of angiotensin I to angiotensin II, which is
the main active product of the RAS [13]. An increased angiotensin
II level causes deleterious effects on renal haemodynamics and
induces the expression of different growth factors and cytokines,
leading to tubulointerstitial fibrosis and glomerulosclerosis [14].
The ACE gene consists of either an insertion (I) allele or a deletion
(D) allele forming three possible genotypes: II, ID and DD [15].
DD homozygous or D allele is associated with elevated circulating
and tissue ACE activity compared to I allele [6,16,17,18]. Patients
with SRNS eventually receive symptomatic treatment with
synergic combinations of angiotensin converting enzyme inhibitors
and angiotensin II receptor blockers as they seem to produce a
nonspecific decrease in the proteinuria and reduce glomerular
transcapillary hydrostatic pressure as well as the synthesis of
profibrotic cytokines that alter glomerular permeability [19].
There might be an association between ACE and the response to
corticosteroid treatment.
The ACE I/D gene polymorphism, correlating with circulating
and cellular ACE concentration [16], might be implicated in the
etiology of SRNS or SSNS and has been investigated in numerous
epidemiologic studies. Most of them were performed in Asian
children, and only a few original investigations were conducted in
Caucasians or Africans. However, the available evidence is weak
for Asians at present, due to sparseness of data or disagreements
among the reported investigations. The geographic and race
difference is an important factor to effect the association between
the gene polymorphism and the susceptibility of renal diseases. So,
in this study, we only included the investigations performed in
Asians.
The evidence from meta-analysis may be powerful when
compared with the individual investigation. In the past years,
there were some meta-analyses to explore the association of ACE
I/D gene polymorphism with the susceptibility of some diseases in
Asians. Some investigators [20][21,22] respectively took a meta-
analysis to investigated the association of ACE I/D gene
polymorphism with immunoglobulin A nephropathy (IgAN) risk,
and found that DD homozygous was associated with an increased
risk of IgAN in Asians. Ji et al [23] conducted a meta-analysis to
explore the association of ACE I/D gene polymorphism with
essential hypertension susceptibility in Asians and found that DD
homozygous was associated with hypertension risk. Zhang et al
[24] performed a meta-analysis to study the relation between ACE
I/D gene polymorphism and the onset of asthma, and observed
that there was an association between D allele or DD genotype
and the asthma susceptibility in Asian population. Whether the
ACE I/D gene polymorphism was associated with the response to
corticosteroid treatment and could predict the treatment response
to steroid in Asian children with INS, there was rare meta-analysis
to investigate. We performed this meta-analysis to investigate
whether the ACE I/D gene polymorphism could become a




1.1 Search strategy for the association of ACE I/D gene
polymorphism with SRNS risk. The relevant studies were
searched from the electronic databases of PubMed, Cochrane
Library and CBM-disc (China Biological Medicine Database) on
September 1, 2010. (Steroid resistant nephrotic syndrome OR
SRNS) AND (Angiotensin converting enzyme OR ACE) was
entered into these databases mentioned above for search.
Additional articles were identified through references cited in
retrieved articles.
1.2 Search strategy for the relationship between ACE I/D
gene polymorphism and SSNS susceptibility. A systematic
literature search in PubMed, Cochrane Library and CBM-disc
was carried out on September 1, 2010 using (Steroid sensitive
nephrotic syndrome OR SRNS) AND (Angiotensin converting
enzyme OR ACE). A search of bibliographies listed in those
published studies was also conducted to identify the additional
publications.
1.3 Search strategy for the I/D gene distribution of ACE
between SRNS and SSNS. PubMed, Cochrane Library and
CBM-disc were searched using (Steroid resistant nephrotic
syndrome OR SRNS) AND (Steroid sensitive nephrotic
syndrome OR SRNS) AND (Angiotensin converting enzyme
OR ACE) as of September 1, 2010, and a search of bibliographies
listed in those published studies was also performed to identify
additional publications.
2. Inclusion and Exclusion Criteria
2.1 Inclusion and Exclusion Criteria for SRNS. Inclusion
criteria: (1) A case–control study; (2) The outcome had to be
SRNS; (3) There had to be at least two comparison groups
(SRNS group vs control group); (4) Investigation was conducted in
children.
Exclusion criteria: (1) Review articles and editorials; (2) Case
reports; (3) Investigation did not provide the detailed data of
genotype distribution; (4) Preliminary results not on ACE I/D
gene polymorphism or outcome; (5) Investigating the role ACE
inhibitor to diseases; (6) Association of ACE I/D gene polymor-
phism with INS but not SRNS.
2.2 Inclusion and Exclusion Criteria for SSNS. Inclusion
criteria: (1) Case–control investigation; (2) The outcome must be
SSNS; (3) There should have at least two comparison groups
(SSNS group vs control group) in the study. (4) Study was
performed in children.
Exclusion criteria: (1) Review articles and editorials; (2) Case
reports; (3) Article did not provide the detail genotype data; (4)
Investigating the association of other genes with SSNS or the
relation between ACE I/D gene polymorphism and other diseases.
(5) Studying the role ACE inhibitor to diseases; (6) Association of
ACE I/D gene polymorphism with INS but not SSNS.
2.3 Inclusion and Exclusion Criteria for studies including
SRNS and SSNS. Inclusion criteria: (1) Case–control study; (2)
The outcome included SRNS and SSNS; (3) Two comparison
groups (SRNS group vs SSNS) in the report was needed. (4)
Investigation was implemented in children.
Exclusion criteria: (1) Case reports, editorials and Review articles;
(2) Investigation did not provide the detailed data of genotype
distribution; (3) Results not on ACE I/D gene polymorphism or
outcome; (4) Investigating the role ACE inhibitor to diseases; (5)
Association of ACE I/D gene polymorphism with INS but not
SRNS and SSNS.
3. Data extraction and synthesis
Two investigators independently extracted the following
information from each eligible study: first author’s surname, year
of publication and the number of cases and controls for ACE
genotype. Frequency of D allele was calculated for case group and
control group, from the corresponding genotype distribution. The
results were compared and disagreements were resolved by
discussion.
Association of ACE with Steroid Responsiveness
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Cochrane Review Manager Version 5 (Cochrane Library, UK)
was used to calculate the available data from each investigation.
The pooled statistic was counted using the fixed effects model and
random effects model, respectively. Results were expressed with
odds ratios (OR) for dichotomous data, and 95% confidence
intervals (CI) were also calculated. P,0.05 was required for the
pooled OR to be statistically significant. I
2 was used to test the
heterogeneity among the included studies. When a P value,0.10
indicated a significant statistical heterogeneity across studies, the
results from the random effects models would be more stable when
compared with those in the fixed effects model, and the final
results for our study would come from those in the random effects
models. In order to avoid excessive comparisons, the OR was
calculated by using three methods: method 1, allele comparison (D
allele vs I allele); method 2, comparing DD homozygous with the
other two combinations (DD vs DI+II); method 2, comparing II
genotype with the other two combinations (II vs DD+DI). A chi-
square (x2) test using a web-based program was applied to
determine if genotype distributions of the control population
reported conformed to Hardy-Weinberg equilibrium (HWE;
P,0.05 was considered significant), and the study that the
genotype distributions in the controls were significantly deviated
from HWE was excluded from our sensitive analysis. All
descriptive data were expressed as mean 6 SD.
Results
1 Study characteristics
1.1 Study characteristics for SRNS. Seven studies were
identified for the analysis of the association between ACE I/D
gene polymorphism and SRNS susceptibility. However, two
investigations [6][25] were performed in Caucasians and
Africans respectively, which were excluded from our meta-
analysis. Finally, five studies [4,8,26,27,28] were recruited into
our investigation for the relationship between ACE I/D gene
polymorphism and SRNS susceptibility (Table 1). Interestingly, all
the recruited investigations were performed in children and those
studies were published in English. The data of our interest were
extracted: first author’s surname, year of publication and the
number of cases and controls for ACE genotype (Table 1). Those
five investigations contained 126 case series and 604 controls. The
average distribution frequency of ACE D allele in patients with
SRNS was 64.40% and the average frequency in controls was
48.23%. The average distribution frequency of D allele in cases
was a little increase when compared with that in control group
(SRNS/control=1.34).
1.2 Study characteristics for SSNS. The search yielded 11
references reporting the association of ACE I/D gene poly-
morphism and the onset of SSNS. One study [29] was excluded
because the distribution of ACE I/D gene polymorphism was not
in detail. Furthermore, one report [6] was conducted in
Caucasians and two [25,30] were in Africans, and these were
excluded from our investigation for the relationship between
ACE I/D gene polymorphism and SSNS risk. Seven studies
[4,8,14,26,27,28,31] were identified for the analysis of the
association between ACE I/D gene polymorphism and SSNS
susceptibility in our final review (Table 2). Interestingly, all the
included studies were performed in children. Five studies were
published in English and two [28,31] in Chinese. Those seven
investigations contained 356 case series and 787 controls. The
average distribution frequency of ACE D allele in children with
SSNS was 50.97%, and the average frequency in controls was
46.68%. The average distribution frequency of D allele in cases
was similar with that in control group (SSNS/control=1.09).
1.3 Study characteristics for studies including SRNS and
SSNS. Five studies [4,8,26,27,28] were included in our investi-
gation to explore whether the ACE I/D gene distributions in
SRNS were different from those in SSNS (Table 3). Those five
investigations contained 126 patients with SRNS and 291 SSNS
children. The average distribution frequency of ACE D allele in
patients with SRNS was 64.40%, and the average frequency in
SSNS was 55.87%. The average distribution frequency of D allele
in SRNS group was slightly increased when compared with that in
SSNS group (SRNS/SSNS=1.15).
2 Association of ACE I/D gene polymorphism with
treatment response to steroid
2.1 Association of ACE I/D gene polymorphism with
SRNS risk. In this meta-analysis, five investigations [4,8,26,27,28]
were included into our study to explore the association of ACE I/D
gene polymorphism with SRNS susceptibility in Asian children.
Pooled OR were computed twice, by using the fixed effects method
and the random effects method (Table 4). Random effects model
were more appropriate when marked heterogeneity was present
among the studies. When the fixed effects method was used to
analysis those associations, the pooled OR of the ACE I/D gene
polymorphism associated with SRNS risk were 1.38(95%CI: 1.04–
1.83) for comparison of D allele vs I allele, 1.26(95%CI: 0.84–1.90)
for comparison of combined wild homozygous and variant
homozygous and heterozygous DD vs DI+II respectively. In the
results of fixed effects method, D allele was associated with the onset
Table 1. Characteristics of the studies evaluating the effects
of ACE I/D gene polymorphism on SRNS risk.
First author,
year Case Control D allele (%) P(HWE)
DD ID II DD ID II Case Control
AI-Eisa 2001 6 2 0 25 22 1 87.50 75.00 0.124
Serdaroglu
2005
34 38 11 99 124 64 63.86 56.10 0.037
Yang 2005 0 5 6 5 22 23 22.73 32.00 0.938
Celik 2006 3 16 0 51 74 15 57.90 62.86 0.118
Tsai 2006 4 1 0 2 20 57 90.00 15.19 0.877
doi:10.1371/journal.pone.0019599.t001
Table 2. Characteristics of the studies evaluating the effects
of ACE I/D gene polymorphism on SSNS onset.
First author,
year Case Control D allele (%) P(HWE)
DD ID II DD ID II Case Control
AI-Eisa 2000 33 8 6 25 22 1 78.72 75.00 0.124
Dang 2000 1 6 15 18 36 53 18.18 33.64 0.011
Oktem 2004 16 19 8 13 53 10 59.30 51.97 0.001
Yang 2005 5 12 12 5 22 23 37.93 32.00 0.938
Serdaroglu 2005 75 49 20 99 124 64 69.10 56.10 0.037
Celik 2006 10 39 3 51 74 15 56.73 62.86 0.118
Tsai 2006 6 2 11 2 20 57 36.84 15.19 0.877
doi:10.1371/journal.pone.0019599.t002
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heterogeneity among the included studies was observed for the
analysis of D vs I or DD vs DI+II (P=0.003, P=0.0008;
respectively; Table 4). The results coming from the random
effects method might be more stable compared with those in the
fixed effects method. In the analysis using the random effects
method, we found that D allele and DD genotype were not
associated with SRNS risk (D: OR=1.60, P=0.26; DD:
OR=1.90, P=0.38; Figure 1-A for D, Figure 2-A for DD;
Table 4). Furthermore, the fixed effects method was performed and
we documented that there was significant association between II
genotype and risk of SRNS relative to both other genotypes
combined when the fixed effects method was used (OR=0.51,
P=0.02; Table 4). Interestingly, II homozygous seemed not to play
a protective role against the onset of SRNS when the random effects
method was conducted (OR=0.55, P=0.23; Table 4). There was
no significantheterogeneityforthe comparison ofII vsDD+DI, and
the result from the fixed effects method might be more suitable for
our investigation. The result for the comparison of II vs DD+DI was
not stable and more investigations were needed to be performed to
study this association.
In conclusion, as the result of that there were notable
heterogeneities among the included studies for the comparisons
of D vs I and DD vs (DI+II) (when significant statistical
heterogeneity was observed among the included studies, the final
results would come from those of the random effects models), the
final results for the analysis of the association of ACE I/D gene
polymorphism with SRNS susceptibility in Asian children were as
follow: D: OR=1.60, P=0.26; DD: OR=1.90, P=0.38; II:
OR=0.51, P=0.02 (Table 4).
Sensitivity analysis. The gene distribution of control group
in the included study was not in HWE, which might be an
important reason to cause heterogeneity to our investigation. In
this meta-analysis, sensitivity analysis was performed. The
genotype distributions of the control population in one study [8]
didn’t conform to HWE and this investigation was excluded from
our study. Finally, four studies [4,26,27,28] were recruited into our
sensitivity analysis.
In the sensitivity analysis, the association of D allele or DD
homozygous with SRNS susceptibility in Asian children wasn’t
observed when fixed effects method or random effects method was
used (Table 4). Combination the results from sensitivity analysis
with those in non-sensitivity analysis mentioned above, we might
draw a stable conclusion that D allele and DD homozygous were
not associated with SRNS susceptibility in Asian children.
The II genotype seemed not to play a protective role against
SRNS risk in our sensitivity analysis when fixed effects method or
random effects method was performed (Table 4). It was
inconsistent with that in non-sensitivity analysis mentioned above,
and the conclusion for II allele in our study was instable.
To sum up, as the result of that marked heterogeneity among
the included studies were observed for all the comparisons (when a
P value,0.10 for heterogeneity test among the included studies
was observed, the final results would come from those in random
effects models), the final results for the analysis of the association of
ACE I/D gene polymorphism with SRNS susceptibility in Asian
children were as follow: D: OR=2.11, P=0.30; DD: OR=2.46,
P=0.48 ; II: OR=0.44, P=0.39 (Table 4).
2.2 Association of ACE I/D gene polymorphism with
SSNS susceptibility. When the fixed effects method was
performed to explore the association between ACE I/D gene
polymorphism and SSNS risk in Asian children, we found D allele
and DD genotype were associated with the risk of SSNS when the
fixed effects method was conducted. However, significant
heterogeneity among the included studies was observed in the
analysis for D allele or DD genotype (P=0.002, P=0.0002;
respectively; Table 5). In the analysis using the random effects
method, we found D allele and DD genotype were not associated
with SSNS risk (D: OR=1.24, P=0.28; DD: OR=1.72, P=0.15;
Figure 1-B for D, Figure 2-B for DD; Table 5). The results coming
from the random effects method might be more stable compared
with those in the fixed effects method.
Furthermore, the association of II genotype with SSNS risk in
Asian children wasn’t observed when the fixed effects method or
the random effects method was used (P=0.35, P=0.85;
respectively; Table 5). The result might be stable and II
Table 3. Gene distribution characteristics of ACE I/D gene for
SRNS and SSNS.
First author,
year SRNS SSNS D allele (%)
DD ID II DD ID II SRNS SSNS
AI-Eisa 2001 6 2 0 33 8 6 87.50 78.72
Serdaroglu 2005 34 38 11 75 49 20 63.86 69.10
Yang 2005 0 5 6 5 12 12 22.73 37.93
Celik 2006 3 16 0 10 39 3 57.90 56.73
Tsai 2006 4 1 0 6 2 11 90.00 36.84
doi:10.1371/journal.pone.0019599.t003
Table 4. Meta analysis for the association of ACE I/D gene polymorphism with SRNS risk.
Comparisons
Studies
number heterogeneity P value Fixed effects model Random effects model
OR (95% CI) P OR (95% CI) P
D vs I 5 0.003 1.38(1.04,1.83) 0.03 1.60(0.71,3.61) 0.26
DD vs (DI+II) 5 0.0008 1.26(0.84,1.90) 0.26 1.90(0.45,8.08) 0.38
II vs (DI+DD) 5 0.17 0.51(0.29,0.88) 0.02 0.55(0.20,1.47) 0.23
Sensitivity analysis
D vs I 4 0.001 1.37(0.85,2.20) 0.20 2.11(0.51,8.66) 0.30
DD vs (DI+II) 4 0.0003 1.16(0.57,2.34) 0.68 2.46(0.20,29.84) 0.48
II vs (DI+DD) 4 0.08 0.47(0.19,1.15) 0.10 0.44(0.07,2.81) 0.39
doi:10.1371/journal.pone.0019599.t004
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of SSNS in Asian children.
In conclusion, as the result of that remarkable heterogeneity
among the included studies was observed for all the comparisons
(when significant statistical heterogeneity was observed among the
included studies, the final results would come from those of the
random effects models), the final results for the analysis of the
association of ACE I/D gene polymorphism with SSNS
Figure 2. Association of DD genotype with SRNS risk and SSNS susceptibility. A: DD genotype and SRNS; B: DD genotype and SSNS.
doi:10.1371/journal.pone.0019599.g002
Figure 1. Association between D allele and SRNS susceptibility or SSNS risk. A: D allele and SRNS; B: D allele and SSNS.
doi:10.1371/journal.pone.0019599.g001
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P=0.28; DD: OR=1.72, P=0.15; II: OR=0.95, P=0.85
(Table 5).
Sensitivity analysis. The gene distributions of control group
in the included studies were not in HWE and those investigations
were excluded from our sensitivity analysis. As a result, the gene
distributions in control group of three studies [8,14,31] didn’t
conform to HWE and those studies were excluded from our study.
Finally, four investigations [4,26,27,28] were recruited into our
sensitivity analysis.
In the sensitivity analysis, the association between D allele or
DD homozygous and risk of SSNS in Asian children wasn’t
observed when fixed effects method or random effects method was
conducted (Table 5). Combination the results coming from
sensitivity analysis with those in non-sensitivity analysis mentioned
above for SSNS, we might draw a stable conclusion that D allele
and DD homozygous were not associated with SSNS susceptibility
in Asian children.
The II genotype seemed not to play a protective role against
SSNS onset in our sensitivity analysis when fixed effects method or
random effects method was performed (Table 5). It was consistent
with that in non-sensitivity analysis mentioned above for SSNS,
and this conclusion for II allele was stable.
To sum up, as the result of that there was notable heterogeneity
among the included studies for the comparisons of D vs I and DD
vs (DI+II) (when a P value,0.10 for heterogeneity test among the
included studies was observed, the final results would come from
those in random effects models), the final results for the analysis of
the association between ACE I/D gene polymorphism and SSNS
risk in Asian children were as follow: D: OR=1.34, P=0.31; DD:
OR=2.04, P=0.30; II: OR=0.83, P=0.51 (Table 5).
2.3 The difference of ACE I/D gene distribution between
SRNS and SSNS. Five investigations [4,8,26,27,28] were re-
cruited into this meta-analysis for the analysis of the difference of
ACE I/D gene distribution between SRNS and SSNS in Asian
children. The difference of ACE I/D gene distribution wasn’t
observed between SRNS and SSNS when fixed effects method or
random effects method was used. The conclusion from the analysis
of the difference of ACE I/D gene distribution between SRNS and
SSNS was stable in this investigation. Consequently, as the result
of that marked heterogeneity among the included studies was
observed in the comparison of D vs I (when significant statistical
heterogeneity was observed among the included studies, the final
results would come from those of the random effects models), the
pooled OR and P value for the difference in finally were as follow:
D allele: OR=1.09, P=0.81; DD: OR=0.75, P=0.22; and II:
OR=0.77, P=0.41(Figure 3-A for D, Figure 3-B for DD;
Table 6).
Discussion
INS is the most common glomerular disease in children and
represents a heterogeneous group of glomerular disorders. It can
be divided into well-defined categories based on the response to
standard prednisolone therapy. Early diagnosis for patient is very
import for improving the prognosis in clinic. Up to now, there is
no early diagnostic measure which can provide a reliable answer to
predict the onset of SRNS. Renal histology detection is helpful to
predict the clinical course of INS in childhood, but there are some
limitations due to sampling, and the renal histology detection also
can’t accurately predict the response to corticosteroid treatment.
Furthermore, it is also difficult to put in practice widely, especially
in some developing country.
The genetic origin of renal diseases had been a focus of research
in the past years; and some investigations found that the genetic
alteration could become an early diagnosis indicator to predict the
onset of some diseases [32,33,34]. There were some significant
evidences showing that the RAS had taken part in the onset of
some renal diseases [9,10,11,12]. The level of plasma ACE,
constitutively expressed in several types of somatic cells, is linked to
an I/D polymorphism of 287 bp in intron 16 of the ACE gene
[35,36,37]. D allele and DD homozygous have been reported to
be associated with higher plasma ACE level [6,16]. ACE is an
important enzyme of RAS which can convert inactive angiotensin
I into a vasoactive and aldosterone-stimulating peptide angiotensin
II [38,39]. The increased ACE protein expression is responsible
for the elevation of plasma angiotensin II level [40]. So, D allele or
DD homozygous might be an important molecular marker for
early diagnosis of the onset of SRNS or SSNS. Most of the studies,
investigating the association between ACE I/D gene polymor-
phism and the response to steroid treatment, were performed in
Asian children with INS and tried to explore whether the ACE I/
D gene polymorphism could become an early diagnosis indicator
to predict the treatment response to steroid. However, data were
insufficient. Furthermore, findings on the association of ACE I/D
gene polymorphism with the susceptibility of SRNS or SSNS have
been controversial since the first investigation was reported. In this
study, we investigated whether the ACE I/D gene polymorphism
could become a valuable indicator to predict the treatment
response to steroid in Asian children with INS and tried to draw a
more credible conclusion by meta-analysis.
In this investigation, we found the difference of association of D
allele or DD genotype with the risk of SRNS or SSNS between
Table 5. Meta analysis for the association of ACE I/D gene polymorphism with SSNS susceptibility.
Comparisons
Studies
number heterogeneity P value Fixed effects model Random effects model
OR (95% CI) P OR (95% CI) P
D vs I 7 0.002 1.31(1.09,1.59) 0.005 1.24(0.84,1.84) 0.28
DD vs (DI+II) 7 0.0002 1.62(1.23,2.13) 0.0007 1.72(0.82,3.60) 0.15
II vs (DI+DD) 7 0.06 0.85(0.61,1.19) 0.35 0.95(0.55,1.63) 0.85
Sensitivity analysis
D vs I 4 0.02 1.15(0.85,1.57) 0.36 1.34(0.76,2.38) 0.31
DD vs (DI+II) 4 0.0003 1.21(0.77,1.91) 0.40 2.04(0.52,7.97) 0.30
II vs (DI+DD) 4 0.18 0.83(0.48,1.44) 0.51 0.81(0.37,1.80) 0.61
doi:10.1371/journal.pone.0019599.t005
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were in agreement with those of sensitive analysis. We also
conducted the analysis for the difference of ACE I/D gene
distribution between SRNS and SSNS, and found the difference of
ACE I/D gene distributions between two groups were not
statistically significant. Our results indicated that ACE D allele
or DD genotype could not predict the treatment response to
steroid in Asian children with INS. The conclusions were stable in
our meta-analysis and they were consistent with the results of some
included studies conducted in Asian children. Yang et al [28]
reported the distributions of ACE I/D gene polymorphism were
not significantly different between group of patient with INS and
healthy control groups, and the distributions of ACE I/D gene
polymorphism in the SSNS group were similar to those in the
SRNS group, so we could draw a reasonable speculation that there
was no significant association between ACE I/D gene polymor-
phism and the onset of SRNS or SSNS. Celik et al [27] observed
that there was no significant association between ACE genotypes
and risk of SSNS or SRNS, and they drew a conclusion that ACE
I/D gene polymorphism did not contribute to the steroid response
for patients with INS. Oktem et al [14] reported that there was no
difference in the ACE I/D gene distribution between children with
focal segmental glomerulosclerosis (most of them were SRNS) and
normal controls. Serdaroglu et al [8] found that the distributions of
ACE gene polymorphism in SSNS were similar to those of SRNS.
Patil et al [29] reported that the frequency of DD genotype in
SSNS patients was similar with that in controls.
However, some other Asian studies had an opinion that there
was an association between ACE I/D gene polymorphism and
treatment response to steroid. Al-Eisa et al [26] found that the INS
cases with DD homozygous showed a significantly higher
incidence for steroid sensitivity and steroid dependence. Tsai et
al [4] reported that the higher incidence of DD genotype was
observed in SSNS group and non-SSNS group, and a higher
percentage of DD genotype in non-SSNS group and in SDNS
group was also noted when compared with that in SSNS group.
They drew a conclusion that DD homozygous might be a risk
factor for INS and played an important role in the clinical
response to steroids for INS patients. Dang et al [31] observed that
the DD genotype distribution in non-SSNS patient was much
higher when compared with that in SSNS and healthy control
group and they drew the conclusion that ACE DD homozygous
was associated with the treatment response of steroid in patient
with INS.
Ethnic ingredient plays an important role in the epidemiology of
INS [5]. In our investigation, we excluded those investigations
Figure 3. D allele or DD genotype distribution difference between SRNS and SSNS. A: D allele; B: DD genotype.
doi:10.1371/journal.pone.0019599.g003
Table 6. Meta analysis for the difference of the ACE I/D gene distribution between SRNS and SSNS.
Comparisons Studies number heterogeneity P value Fixed effects model Random effects model
OR (95% CI) P OR (95% CI) P
D vs I 5 0.05 0.94(0.69,1.30) 0.72 1.09(0.56,2.11) 0.81
DD vs (DI+II) 5 0.24 0.75(0.48,1.19) 0.22 0.86(0.41,1.82) 0.69
II vs (DI+DD) 5 0.35 0.77(0.42,1.42) 0.41 0.83(0.39,1.76) 0.63
doi:10.1371/journal.pone.0019599.t006
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Sasse et al [6] found there was no significant correlation between
ACE genotype and steroid responsiveness in Swiss children with
INS. Saber-Ayad et al [30] revealed that no association between
ACE I/D gene polymorphism and risk of SSNS or non-SSNS by
investigating the characteristics of ACE I/D gene distributions in
Egyptian children with INS. The results of Sasse et al in Caucasian
children and Saber-Ayad et al for African children were similar to
those in our study, which was drew from Asian children with INS.
However, in Africans, Fahmy et al [25] found that DD genotype
might play a key role in the clinical response to steroid in Egyptian
children with INS, but the difference of DD genotype between
SSNS group and control group was not significant. For the
analysis of DD homozygous, there was a significant difference
between non-SSNS, SDNS and SRNS versus controls. For the
analysis of D allele, a significant difference was observed between
SSNS, SDNS and SRNS versus controls. The results of Fahmy
et al [25] could draw a conclusion that ACE I/D gene
polymorphism was associated with the treatment response of
steroid in African children with INS. In conclusion, the role of
ACE I/D gene polymorphism for SRNS and SSNS in Caucasian
children and African children might be different from that in
Asian children, and the number of the included studies was small
and it was difficult to draw a stable conclusion for the association
of ACE I/D gene polymorphism and the onset of SRNS or SSNS
in Caucasian children and African children (only 1 report for
Caucasian children and 2 investigations in African children). We
excluded those investigations from our meta-analysis.
Our results indicated that there was no an association between
ACE I/D gene polymorphism and the treatment response of
steroid in Asian children with INS. The outcome might be stable.
Our conclusion was inconsistent with those from the meta-analysis
for the association between ACE I/D gene polymorphism and
other diseases [20][21][23][24] in Asian population. We specu-
lated that the association of ACE I/D gene polymorphism with
different diseases was different in Asians, and the ACE I/D gene
polymorphism was not associated with the response to steroid
treatment in Asian children with INS. However, those findings
should be regarded cautiously because many other ingredients,
such as heterogeneity of enrolled cases, limited statistical power,
variable study designs and different interventions, were closely
related to affect the results. Furthermore, whether the I/D gene
polymorphism is just linked with other discrete loci involved in the
occurrence of SRNS or SSNS is not clear at the moment.
In conclusion, the results in our study support that DD genotype
or D allele is not associated with the susceptibility of SRNS or
SSNS in Asian children, and DD genotype or D allele can’t
become a significant genetic molecular marker to predict the
treatment response to steroid for children with INS. However,
more case-control association investigations on larger, stratified
populations are required to further clarify the role of the ACE I/D
gene polymorphism in predicting the treatment response to
glucocorticosteroid. More case-control investigations also should
be conducted in Caucasians and African population for investi-
gating the association between ACE I/D gene polymorphism and
the response to steroid treatment in patient with INS.
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